共 9 条
[1]
Joint effects of an aldosterone synthase(CYP11B2 ) gene polymorphism and classic risk factors on risk of myocardial infarction. Hautanen A, Toivanen P, Manttari M, et al. Circulation . 1999
[2]
Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese:the Suita Study. Tsujita Y, Iwai N, Katsuya T, et al. Hypertension Research . 2001
[3]
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Rigat B, Hubert C, Alhenc-Gelas F, et al. The Journal of Clinical Investigation . 1990
[4]
Aldosterone synthase (CYP11B2)polymorphisms and cardiovascular function. White PC, Hautanen A, Kupari M. Journal of Steroid Biochemistry . 1999
[5]
Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Brand E, Chatelain N, Mulatero P, et al. Journal of Hypertension . 1998
[6]
Genetic polymorphism of CYP11B gene and hypertension in Japanese. Tamaki S, Iwai N, Tsujita Y, et al. Journal of Hypertension . 1999
[7]
Mineralocorticoids, hypertension and cardiac fibrosis. Young M, Fullerton M, Dilley R, et al. The Journal of Clinical Investigation . 1994
[8]
Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Devereux RB, Koren MJ, de Simone G, et al. European Heart Journal . 1993
[9]
Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Kupari M, Hautanen A, Lankinen L, et al. Circulation . 1998